Is Bunge Worth Buying as Oilseed Strength Meets Integration Risks?

Bunge's Q2 2026 soybean processing and refining adjusted EBIT rose 46.4% year over year to $445 million, while softseed processing EBIT increased to $255 million from $14 million, supported by oilseed demand and expanded Viterra capacity. Management lifted the Viterra cost-synergy target to about $350 million, with 2026 and 2027 consensus earnings growth estimated at 28.4% and 24.3%, respectively. Offsetting the operational upside, Bunge lowered its 2026 outlook for Grain Merchandising and Milling; ROIC of 6.7% trails its 7.8% 10-year median, free-cash-flow conversion is negative 69.2%, and its 10.46x forward P/E exceeds both its five-year median and sub-industry valuation.

Analysis

The investable issue is not headline earnings momentum but whether BG can convert a larger, more geographically diversified asset base into lower earnings volatility and working-capital discipline. Processing margins can remain strong while cash generation deteriorates if inventories and receivables expand into a commodity-price upswing; that would cap deleveraging and make the equity increasingly sensitive to crush-margin normalization. The stated synergy ambition is meaningful only if it appears in cash operating costs rather than being offset by integration spending, higher maintenance capex, or incremental logistics complexity.

BG's enlarged origination footprint may improve optionality during regional crop disruptions, but it also raises exposure to basis risk, freight dislocations and sovereign/currency friction in Argentina and other export markets. ADM is the cleaner public read-through on North American crushing economics but lacks the same integration catalyst; BG should outperform ADM over the next 6-12 months only if it demonstrates both synergy realization and stable segment profitability outside oilseeds. DAR is a less direct beneficiary: sustained renewable-diesel economics support feedstock demand, but higher yellow-grease and vegetable-oil values can compress its input-cost spread rather than provide a one-way positive.

Consensus may be underweighting the duration of biofuel-led vegetable-oil demand, but it is also likely assigning too much certainty to EPS growth before cash conversion normalizes. A modest premium to BG's own historical multiple is defensible if ROIC rises toward the peer range; absent that, the stock can de-rate even with earnings growth. Near-term catalysts are quarterly segment margins, synergy run-rate disclosure and working-capital release; the 6-18 month catalyst is whether post-integration capex and interest burden fall fast enough to support sustainable buybacks or debt reduction.

Key Decisions for Investors

• Maintain BG as a watch-list long rather than initiate at current valuation; add only after a quarterly report shows positive free-cash-flow conversion and management quantifies realized, not targeted, Viterra synergies. Target 10-15% upside over 6-12 months if ROIC trends above 8%; exit on another full-year grain-guidance reduction or failure to improve cash conversion.
• Use a relative-value structure: long BG / short ADM in equal dollar amounts only following evidence of synergy capture, with a 6-9 month horizon. The trade isolates BG's integration optionality from broad oilseed-crush exposure; stop out if BG's oilseed margin advantage narrows for two consecutive quarters or ADM's North American crush results materially accelerate.
• Do not chase DAR as a biofuel proxy. Monitor renewable-diesel utilization, yellow-grease pricing and soybean-oil spreads; consider DAR only if feedstock inflation stabilizes while its downstream fuel margins recover, since elevated lipid prices can be a cost headwind.
• Set event alerts for Argentine export-tax/currency policy, global soybean crush spreads, and BG net working-capital movements. These are more decision-relevant over the next 1-3 months than consensus EPS revisions, which can lag commodity-margin reversals.